U.S. Markets closed

Shire plc (SHPG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
174.92+4.17 (+2.44%)
At close: 4:00PM EDT

174.99 0.07 (0.04%)
After hours: 4:11PM EDT

People also watch
ALXNJAZZBMRNREGNBAX
Full screen
Previous Close170.75
Open173.68
Bid168.20 x 100
Ask205.00 x 100
Day's Range173.31 - 176.29
52 Week Range161.09 - 209.22
Volume1,628,945
Avg. Volume1,072,756
Market Cap52.53B
Beta1.73
PE Ratio (TTM)179.41
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.91 (0.54%)
Ex-Dividend Date2017-03-08
1y Target EstN/A
Trade prices are not sourced from all markets
  • Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
    Zacks7 hours ago

    Shire (SHPG) Receives MAA Validation for Veyvondi by EMA

    Shire plc (SHPG) announced that the European Medicines Agency (EMA) validated the Marketing Authorization Application (MAA) for Veyvondi to prevent and treat bleeding episodes and peri-operative bleeding in adults diagnosed with von Willebrand Disease.

  • TheStreet.com8 hours ago

    Biotech Movers: Shire, Bellicum, Organovo

    Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.

  • Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US
    Zacksyesterday

    Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US

    Shire Plc (SHPG) announced that the FDA has approved its new attention deficit hyperactivity disorder (ADHD) drug, Mydayis (mixed salts of a single-entity amphetamine product) in patients 13 years and older